A commonly prescribed painkiller and anticonvulsant (seizure medication) widely believed to be “benign” has become increasingly associated with overdose deaths in the United States. The medication is gabapentin, commonly marketed as Neurontin, Horizant, and Gralise. Over the years, gabapentin prescribing has steadily increased, with 64 million prescriptions dispensed in 2016, making the drug the 10th…
Highly Prescribed ‘Benign’ Medication Detected in 10 Percent of Overdose Deaths
July 13, 2022
admin
BrighthealthHealth 1+1health care systemHealth SciencemedicineMen's Healthoff-labelpainkillerPfizerThe Food and Drug AdministrationUSUS News
0 Comment
Drugs With High Abuse Potential Six Times More Likely to Be Approved for Pain Medication, Study Finds
A study has found that drugs with high abuse potential are around six times more likely to be approved as compared to drugs with low abuse potential for pain medications. “The probability of successful development programs was 27.8 percent for high abuse potential compounds and 4.7 percent for low abuse potential compounds,” the authors wrote…
Bankruptcy Judge Approves Purdue Pharma’s $7 Million Executive Bonus Plan
A bankruptcy judge on Monday approved up to $7.1 million in bonuses for five executives of Purdue Pharma, the bankrupt maker of OxyContin, at a hearing at which he faced blunt criticism for his handling of the case from a woman whose son died of an opioid overdose. Bankruptcy Judge Robert Drain in White Plains,…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta